Autifony Therapeutics is a startup based in the United Kingdom.
Based in the United Kingdom, Autifony Therapeutics is a startup.
Autifony Therapeutics is a clinical-stage biotechnology company based in the UK that develops novel ion channel modulators to treat rare and serious central nervous system (CNS) disorders including Fragile X syndrome and orphan epilepsy syndromes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.